Testing Services
Browse by Category
All prices per sample. No quotes required for standard panels. Turnaround 5–11 days from receipt.
Analytical Testing Services
Independent third-party verification for purity, identity, potency, contaminants, and sterility.
Supplier COAs are not independent verification.
73% of peptide samples tested independently show purity discrepancies from their supplier-issued COAs. The gap between claimed and actual is not rare — it is the norm.
GLP-1 clinics, 503A compounding pharmacies, and research vendors all operate in a supply chain where self-reported quality documentation is the primary safeguard. It is not sufficient.
Atumnus Labs provides the independent analytical layer. HPLC purity, LC-MS identity, potency, heavy metals, endotoxin, and sterility — third-party confirmed, full instrument data in every COA.
Purity, identity, potency, confirmed.
RP-HPLC chromatographic purity analysis confirms the percentage of target peptide versus impurities, deletion sequences, and synthesis by-products. LC-MS identity confirmation verifies molecular weight against reference standards — not a substitute, the actual compound.
Potency testing confirms vial fill against stated label claim, adjusted for moisture, salts, and counter-ions that affect gross weight calculations.
View Chemical Tests →
Endotoxin and sterility. Required for injectables.
Bacterial endotoxin by LAL assay per USP 85. Sterility by standard USP 71 method or rapid Celsis returning results in 5–7 days rather than the 14-day hold. Method suitability studies available for validated repeat testing programs.
Every injectable peptide product requires both. Neither can be reliably inferred from chemical testing alone.
View Biological Tests →
The vial says 99% pure. The HPLC says 67%. Independent testing is not optional — it is the only way to know.
Three client segments where independent verification is non-negotiable.
Semaglutide, tirzepatide, and BPC-157 programs require verified purity and potency before patient dosing. COA documentation for clinical records and state board compliance.
Compounding pharmacies require third-party batch release testing. Full Injectable Panel returns purity, potency, metals, endotoxin, and sterility in one submission — board-ready COA format.
Suppliers and researchers sourcing from multiple vendors use Atumnus for independent supplier qualification, batch comparison, and quality program documentation.
Validated once. Repeatable every time.
Method suitability studies are required before sterility and endotoxin results are analytically valid for a specific formulation. Atumnus provides suitability protocols for sterility ($1,800), endotoxin ($675), and potency ($1,200).
Validated once per formulation — every subsequent test runs against a confirmed methodology. The right foundation for any repeat testing program.
Discuss your program →